Reported Earlier, Boston Scientific Priced Public Offering Of €750M 3.375% Notes Due 2029 And €1.25B 3.500% Notes Due 2032
Portfolio Pulse from Benzinga Newsdesk
Boston Scientific Corporation (BSX) announced its finance subsidiary, American Medical Systems Europe B.V., has priced a public offering of €750M 3.375% notes due 2029 and €1.25B 3.500% notes due 2032, fully guaranteed by BSX. The offering is under a registration statement filed with the U.S. SEC.

February 23, 2024 | 7:35 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Boston Scientific Corporation announced a public offering of €750M and €1.25B notes due 2029 and 2032, respectively, guaranteed by the company.
The successful pricing of a significant public offering of notes indicates a strong financial maneuver by Boston Scientific, likely to be viewed positively by investors. It suggests confidence in the company's financial health and future prospects, potentially leading to a positive short-term impact on BSX's stock price. The guarantee by BSX underscores its commitment and stability, further enhancing investor confidence.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100